Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Biosimilars Clinical'

Biosimilars Clinical published presentations and documents on DocSlides.

ASBM Biosimilars US Prescribers and Biosimilars Naming
ASBM Biosimilars US Prescribers and Biosimilars Naming
by min-jolicoeur
Kevin Olson, CEO. Industry Standard Research. Kev...
Latin American Biologics/Biosimilars Conference
Latin American Biologics/Biosimilars Conference
by giovanna-bartolotta
Presented by . the Alliance for Safe Bioloigic . ...
ASBM Biosimilars
ASBM Biosimilars
by phoebe-click
US Prescribers and Biosimilars Naming. Kevin Olso...
US Regulatory Pathway For Biosimilars
US Regulatory Pathway For Biosimilars
by cheryl-pisano
Practical Legal/Regulatory Considerations Arising...
Biosimilars in the Real World
Biosimilars in the Real World
by liane-varnes
Introduction/Overview . PLANETRA Extension Study:...
Applying Biosimilars in Hematologic Cancers
Applying Biosimilars in Hematologic Cancers
by conchita-marotz
This program will include a discussion of off-lab...
Biosimilars are effective and safe and should immediately replace innovator molecules in the NHS
Biosimilars are effective and safe and should immediately replace innovator molecules in the NHS
by myesha-ticknor
Dr Chris Deighton. Consultant Rheumatologist . Co...
Building a Biosimilars Pathway in the U.S.
Building a Biosimilars Pathway in the U.S.
by attentionallianz
Richard . Dolinar. , MD. Endocrinologist, Chairman...
Synergy Satellite Event - Biosimilars in colorectal cancer
Synergy Satellite Event - Biosimilars in colorectal cancer
by mia
– what's your gut feeling?. 25th Anniversary EAH...
A QUM partnership approach to regulating
A QUM partnership approach to regulating
by liane-varnes
biosimilars. in Australia. David Lim, Evan Siege...
Biosimilars in the united states – Update on FDA Impleme
Biosimilars in the united states – Update on FDA Impleme
by test
James C. Shehan. Hyman, Phelps & McNamara, P....
Distinguishable INNs: A Global Solution
Distinguishable INNs: A Global Solution
by trish-goza
Richard . Dolinar. , MD. Chairman, Alliance for S...
United Spinal Association
United Spinal Association
by alida-meadow
August, 2014. Biologics & Biosimilars: . An O...
About OMICS Group OMICS Group International is an amalgamation of 
About OMICS Group OMICS Group International is an amalgamation of 
by sherrill-nordquist
Open Access publications.  and worldwide interna...
Bio similars A Presentation
Bio similars A Presentation
by kittie-lecroy
By. ANSHUL . SHARMA. Graduate Research Scholar. D...
Latin American Physician Perspectives on Biosimilars
Latin American Physician Perspectives on Biosimilars
by celsa-spraggs
Presented at the . Latin American Biologics/Biosi...
CHALLENGES FACED IN THE DEVELOPMENT OF BIOSIMILARS
CHALLENGES FACED IN THE DEVELOPMENT OF BIOSIMILARS
by iamamercy
Dr.G.Hima. . Bindu. ...
Budget impact and cost-effectiveness of oncology
Budget impact and cost-effectiveness of oncology
by roxanne
biosimilars. Prof. dr. Steven Simoens. Health econ...
Biosimilars: Additional Questions and Answers Regarding Implementatio
Biosimilars: Additional Questions and Answers Regarding Implementatio
by mitsue-stanley
&#x/Att;¬he; [/; ott;&#xom ];&#x/BBo...
Biosimilars: Questions and Answers Regarding Implementation of the Bi
Biosimilars: Questions and Answers Regarding Implementation of the Bi
by danika-pritchard
&#x/Att;¬he; [/; ott;&#xom ];&#x/BBo...
Biosimilars: Questions and Answers Regarding Implementation of the Bi
Biosimilars: Questions and Answers Regarding Implementation of the Bi
by sherrill-nordquist
&#x/Att;¬he; [/; ott;&#xom ];&#x/BBo...
Roche Position
Roche Position
by faustina-dinatale
1 1 on Similar Biotherapeutic Products – B...
Biosimilars: Additional Questions and Answers Regarding Implementatio
Biosimilars: Additional Questions and Answers Regarding Implementatio
by liane-varnes
&#x/Att;¬he; [/; ott;&#xom ];&#x/BBo...
Interchangeable Biosimilars: The Future of Affordable MedicineFDA is i
Interchangeable Biosimilars: The Future of Affordable MedicineFDA is i
by celsa-spraggs
Interchangeability = SubstitutabilityInterchangeab...
Phil Johnson MS
Phil Johnson MS
by stefany-barnette
RPh. Safe School Meds, Principle Partner. Moffitt...
Biosimilars 2012 AIPLA Webinar
Biosimilars 2012 AIPLA Webinar
by stefany-barnette
September 25, 2012. 1. Denise. Kettelberger, PhD...
Biosimilars: Regulation and Litigation
Biosimilars: Regulation and Litigation
by mitsue-stanley
Agenda. Key Regulatory Exclusivities for Biologic...
Phil Johnson MS RPh Safe School Meds, Principle Partner
Phil Johnson MS RPh Safe School Meds, Principle Partner
by yoshiko-marsland
Moffitt Cancer Center, Director of Pharmacy (Reti...
U.S. Biosimilars: An Introduction
U.S. Biosimilars: An Introduction
by calandra-battersby
Disclaimers. :. By 2016, 7 of the top 10 pharmace...
TEVA PHARMACEUTICALS
TEVA PHARMACEUTICALS
by adah
Athlani. Audrey ; . Durlin. Stéphanie ; Jauregu...
INSIGHTS INTO THE MARKET
INSIGHTS INTO THE MARKET
by summer
FOR INFLIXIMABTable of ContentsThe Evolving Landsc...
JMP for Biosimilars : Tools for Analytical Similarity
JMP for Biosimilars : Tools for Analytical Similarity
by erica
Sept 16, 2015. W. Heath Rushing, . Adsurgo. LLC. ...